Back to Candriam S.C.A. Candriam S.C.A.

ALLOALLO
Showing 3 of 6 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in ALLOGENE THERAPEUTICS INC

Candriam S.C.A. holds 4.3M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $9M as of 2026-Q2. The position was increased (+44.7% shares). ALLO represents 0.0% of Candriam S.C.A.'s portfolio.

Current Value

$9M

Current Shares

4.3M

Total Value Change

+$5.9M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.3M
+44.7%
$9M0.0%$2.08
37
2026-Q1
Increased
3M
+30.0%
$7.3M0.0%$2.53
34
2025-Q4
New
2.3M
-
$3.2M0.0%$1.31
37

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used